Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1052]

Researchers capture first signs of ovarian cancer risk

Researchers capture first signs of ovarian cancer risk

New review highlights bone health risks linked to modern cancer treatments

New review highlights bone health risks linked to modern cancer treatments

The glucocorticoid receptor is a double-edged sword in prostate cancer

The glucocorticoid receptor is a double-edged sword in prostate cancer

Patients are opting in for 10 years of breast cancer treatment

Patients are opting in for 10 years of breast cancer treatment

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

ASCO 2025: Rusfertide shows promise for polycythemia vera treatment

ASCO 2025: Rusfertide shows promise for polycythemia vera treatment

ASCO 2025: Switch to camizestrant after liquid biopsy detection of breast cancer recurrence improves outcomes

ASCO 2025: Switch to camizestrant after liquid biopsy detection of breast cancer recurrence improves outcomes

ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast cancer

ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast...

ASCO 2025: Menopause drug duavee may help prevent invasive breast cancer

ASCO 2025: Menopause drug duavee may help prevent invasive breast cancer

Breast cancer death rates will rise in elderly EU patients but fall for all other ages

Breast cancer death rates will rise in elderly EU patients but fall for all other ages

More from ecancer